TNF and neoplasm: In clinical trials (primarily in sarcomas), TNFα was often administered locally, in order to generate high tumor concentration of the cytokine; although these trials have led to tumor regression (to various extents in the different trials), usually they did not have a pronounced ability to induce complete remission (16, 18, 19).